Product NDC: | 66758-055 |
Proprietary Name: | Idarubicin Hydrochloride |
Non Proprietary Name: | Idarubicin Hydrochloride |
Active Ingredient(s): | 1 mg/mL & nbsp; Idarubicin Hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66758-055 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091293 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110329 |
Package NDC: | 66758-055-03 |
Package Description: | 10 mL in 1 VIAL, SINGLE-USE (66758-055-03) |
NDC Code | 66758-055-03 |
Proprietary Name | Idarubicin Hydrochloride |
Package Description | 10 mL in 1 VIAL, SINGLE-USE (66758-055-03) |
Product NDC | 66758-055 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Idarubicin Hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110329 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | IDARUBICIN HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |